These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
813 related items for PubMed ID: 11032017
1. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Elliott K, Ge K, Du W, Prendergast GC. Oncogene; 2000 Sep 28; 19(41):4669-84. PubMed ID: 11032017 [Abstract] [Full Text] [Related]
2. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM, Muller AJ, Prendergast GC. Oncogene; 2003 Jun 05; 22(23):3578-88. PubMed ID: 12789266 [Abstract] [Full Text] [Related]
4. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC. Oncogene; 1999 Jun 17; 18(24):3564-73. PubMed ID: 10380878 [Abstract] [Full Text] [Related]
5. v-Jun sensitizes cells to apoptosis by a mechanism involving mitochondrial cytochrome C release. MacLaren A, Clark W, Gillespie DA. Oncogene; 2000 Nov 30; 19(51):5906-18. PubMed ID: 11127822 [Abstract] [Full Text] [Related]
6. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D. J Cell Physiol; 2008 Sep 30; 216(3):621-31. PubMed ID: 18348166 [Abstract] [Full Text] [Related]
7. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM. Oncogene; 2001 Mar 01; 20(9):1063-75. PubMed ID: 11314043 [Abstract] [Full Text] [Related]
8. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. Wu SJ, Ng LT, Lin CC. Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126 [Abstract] [Full Text] [Related]
9. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL. Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823 [Abstract] [Full Text] [Related]
10. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Jänicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K, Wesselborg S. Oncogene; 2000 Sep 21; 19(40):4563-73. PubMed ID: 11030145 [Abstract] [Full Text] [Related]
11. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells. You KR, Shin MN, Park RK, Lee SO, Kim DG. Hepatology; 2001 Dec 21; 34(6):1119-27. PubMed ID: 11732001 [Abstract] [Full Text] [Related]
12. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno M, Yokoyama S, Kuchino Y. Oncogene; 1999 Apr 01; 18(13):2281-90. PubMed ID: 10327074 [Abstract] [Full Text] [Related]
13. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT. Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630 [Abstract] [Full Text] [Related]
14. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. Pineda-Lucena A, Ho CS, Mao DY, Sheng Y, Laister RC, Muhandiram R, Lu Y, Seet BT, Katz S, Szyperski T, Penn LZ, Arrowsmith CH. J Mol Biol; 2005 Aug 05; 351(1):182-94. PubMed ID: 15992821 [Abstract] [Full Text] [Related]
15. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC. Nat Genet; 1996 Sep 05; 14(1):69-77. PubMed ID: 8782822 [Abstract] [Full Text] [Related]
16. E2F activity is essential for survival of Myc-overexpressing human cancer cells. Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J. Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753 [Abstract] [Full Text] [Related]
17. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein. Galderisi U, Di Bernardo G, Cipollaro M, Jori FP, Piegari E, Cascino A, Peluso G, Melone MA. J Cell Biochem; 1999 Sep 01; 74(3):313-22. PubMed ID: 10412034 [Abstract] [Full Text] [Related]
18. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation. Amanullah A, Liebermann DA, Hoffman B. Oncogene; 2002 Feb 28; 21(10):1600-10. PubMed ID: 11896589 [Abstract] [Full Text] [Related]
19. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis. Kangas A, Nicholson DW, Hölttä E. Oncogene; 1998 Jan 22; 16(3):387-98. PubMed ID: 9467964 [Abstract] [Full Text] [Related]
20. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells. Brás A, Albar JP, Leonardo E, de Buitrago GG, Martínez-A C. Cell Death Differ; 2000 Mar 22; 7(3):262-71. PubMed ID: 10745271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]